JVJuan Vicenty-Padilla

Juan Vicenty-Padilla

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Juan Vicenty-Padilla has a total of 66 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Adult presentation of a vein of Galen malformation as cognitive decline in a 47-year-old multiparous female: illustrative case

    by Esteban Rivera-Rivera, Karen S. Chen, Joshua D. Bernstock, Nirav J. Patel, Gisela Murray-Ortiz, Juan Vicenty-Padilla

    BACKGROUND: Vein of Galen malformations (VOGMs) are congenital arteriovenous shunts that typically present in neonates and infants. Symptomatic neonates have a poor prognosis and face high mortality without dedicated neonatal intensive care and pediatric neurointervention in specialized centers. OBSERVATIONS: The authors present the case of a 47-year-old Puerto Rican female with a history of chronically compensated heart failure, progressive cognitive decline, and new-onset seizures. On presentation, the patient had a Glasgow Coma Scale score of 6, and CT imaging revealed intraventricular hemorrhage, extensive parenchymal calcifications, and hydrocephalus. An external ventricular drain was urgently placed, and further workup at the authors’ institution, including CT angiography and digital subtraction angiography, led to the diagnosis of a choroidal VOGM. The patient’s family opted for withdrawal of care without pursuing further neurosurgical intervention. LESSONS: The presentation of a choroidal VOGM at this advanced age is exceptionally rare. This case highlights the importance of understanding the presentations and consequences of this life-threatening condition, as well as considering endovascular or microsurgical intervention. Specifically, workup for cerebrovascular abnormalities should be strongly considered in patients with neurodegenerative presentations at atypical ages without a clear cause, as early diagnosis and management can significantly impact patient outcomes. https://thejns.org/doi/10.3171/CASE25684

  • Open Access

    Prehospital Detection of Large Vessel Occlusion and Intracerebral Hemorrhage Using a Dual-Biomarker Point-of-Care Test

    by Arnab Ghosh, Noah L.A. Nawabi, Diana Alcedo, Rodolfo E. Alcedo Guardia, Juan Vicenty-Padilla, Saef Izzy, Nirav J. Patel, Rose Du, Adam A. Dmytriw, Alfred P. See, et al.

    BACKGROUND: Timely identification of stroke subtype is critical for triage and treatment. Existing prehospital stroke scales have limited diagnostic accuracy, especially in differentiating large vessel occlusion (LVO) from intracerebral hemorrhage (ICH). The LVOne point-of-care test measures d -dimer and GFAP (glial fibrillary acidic protein), biomarkers associated with thrombotic and hemorrhagic stroke, enabling biologically informed triage. METHODS: We validated a new version of the LVOne assay using plasma samples from 210 suspected stroke patients presenting within 6 hours of symptom onset, enrolled in the TIME (Testing of Identification Markers for Stroke) prospective observational cohort. This article reports a retrospective (secondary) laboratory analysis of these prospectively collected samples and clinical data. Samples were collected before neuroimaging or thrombolysis. LVOne version 1 combined d -dimer positivity, GFAP negativity, and Field Assessment Stroke Triage for Emergency Destination scoring for LVO detection only; version 2 uses improved GFAP measurement and a clinical decision rule enabling simultaneous diagnosis of LVO and ICH. Diagnostic performance (sensitivity, specificity, positive predictive value, negative predictive value) was calculated for each version. Receiver operating characteristic analyses and biomarker correlations with Field Assessment Stroke Triage for Emergency Destination were also performed. RESULTS: Both LVOne versions achieved high accuracy for LVO detection (sensitivity, 0.75; specificity, 0.92; negative predictive value, 0.97). Version 2 improved ICH specificity (0.99 versus 0.90) and positive predictive value (0.83 versus 0.23) versus version 1. Biomarker levels correlated with Field Assessment Stroke Triage for Emergency Destination scores but with limited explanatory power (GFAP R 2 =0.077; d -dimer R 2 =0.047), suggesting added information beyond clinical severity scales. In a specimen-matrix comparison (n=25), qualitative GFAP/ d -dimer classification was concordant across plasma, venous whole blood, and capillary whole blood. CONCLUSIONS: The updated LVOne assay enables simultaneous biomarker-based identification of both LVO and ICH in suspected stroke patients. Its rapid, low-complexity format supports prehospital use and may improve triage, reduce time to treatment, and optimize outcomes. Prospective field validation is warranted. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT04292600.


  • Evaluating Prehospital Stroke Scales for Large Vessel Occlusion

    by Noah Lee Ahmad Nawabi, Esteban Rivera Rivera, Daniel de Wilde, John L. Kilgallon, David I. Nawabi, Varun M. Bhave, Patrick Emedom-Nnamdi, Ari Kappel, Shivani D. Rangwala, Rodolfo E. Alcedo Guardia, et al.

    Ischemic stroke remains a leading cause of death and disability worldwide, with large vessel occlusion (LVO) accounting for a disproportionate share of poststroke morbidity. Early identification of LVO is essential for timely intervention with endovascular thrombectomy; however, the clinical scales currently used for triage vary widely in their application and accuracy. This study assesses the diagnostic performance of clinical stroke scales in predicting LVO. A systematic review was conducted to identify studies evaluating the diagnostic accuracy of prehospital stroke scales for detecting LVO. Pooled sensitivity and specificity were estimated using a bivariate random-effects model, with diagnostic performance further assessed through summary receiver operating characteristic (ROC) curves and area under the curve (AUC) analysis. A Bayesian network meta-analysis was conducted to rank the scales using surface under the cumulative ranking (SUCRA) probabilities, and post hoc analyses were performed to evaluate publication bias. A total of 58 studies comprising 58,381 patients and 33 unique stroke scales were included in the final analysis. The studies, published between 2014 and 2023, were primarily conducted in North America (50%) and Europe (26%), with a median sample size of 473 participants. Pooled sensitivity ranged from 0.30 (HEMIPARESIS) to 0.99 (LARIO) while specificity varied from 0.34 (FANG) to 0.94 (HEMIPLEGIA). Among the highest-performing scales overall were LARIO (AUC = 0.983), FPSS (AUC = 0.896), FACE2AD (AUC = 0.876), and ACT-FAST (AUC = 0.873). In prehospital settings, FPSS (AUC = 0.896), FAST VAN (AUC = 0.878), and FACE2AD (AUC = 0.876) demonstrated strong performance while LARIO (AUC = 0.983) and ACT-FAST (AUC = 0.883) showed the highest accuracy in hospital settings. Bayesian network meta-analysis identified POMONA (SUCRA = 0.877), NIHSS (0.856), sNIHSS EMS (0.854), G-FAST (0.823), and SAFE (0.788) as the top-ranked scales. Funnel plot analysis revealed minimal publication bias among the most frequently evaluated tools, including RACE, CPSS, and NIHSS. Numerous clinical scales are available for detecting LVO in the prehospital setting. While several demonstrate strong performance in specific contexts, there remains a clear need for a simple, accurate, and generalizable tool to reliably identify patients with LVO across diverse clinical environments.


  • Open Access

    A unique management strategy to bilateral vertebral artery occlusion following cervical trauma: illustrative case

    by Carlos E. Calderón-Valero, Esteban Rivera-Rivera, Emil Pastrana-Ramírez, Juan C. Vicenty-Padilla

    BACKGROUND: Traumatic vertebral artery injury (TVAI) is a serious yet underdiagnosed complication of cervical spine trauma, with an incidence ranging from 0.1% to 3.2%. While its neurological sequelae vary, the risk of vertebrobasilar ischemia can be as high as 33.3%. The authors present a rare case of bilateral vertebral artery occlusion with concomitant basilar artery occlusion following C4–5 anterolisthesis. OBSERVATIONS: The patient initially exhibited no clinical signs of vertebrobasilar ischemia. Diagnosis was achieved through vascular imaging, and successful endovascular thrombectomy with thrombus removal was performed. Unique to this case, manual cervical reduction was carried out in the endovascular suite while maintaining catheter placement in an effort to prevent recurrent dissection or emboli migration. LESSONS: Given the transient nature of vertebrobasilar ischemia, repeated imaging and neurological monitoring are crucial for timely intervention. This case highlights the importance of establishing standardized screening and treatment protocols to optimize outcomes and prevent further complications in patients with TVAI. https://thejns.org/doi/10.3171/CASE25155

  • Open Access

    Endovascular Applications for the Management of High-Grade Gliomas in the Modern Era

    by Ari D. Kappel, Rohan Jha, Saibaba Guggilapu, William J. Smith, Abdullah H. Feroze, Adam A. Dmytriw, Juan Vicenty-Padilla, Rodolfo E. Alcedo Guardia, Florian A. Gessler, Nirav J. Patel, et al.

    High-grade gliomas (HGGs) have a poor prognosis and are difficult to treat. This review examines the evolving landscape of endovascular therapies for HGGs. Recent advances in endovascular catheter technology and delivery methods allow for super-selective intra-arterial cerebral infusion (SSIACI) with increasing precision. This treatment modality may offer the ability to deliver anti-tumoral therapies directly to tumor regions while minimizing systemic toxicity. However, challenges persist, including blood–brain barrier (BBB) penetration, hemodynamic complexities, and drug–tumor residence time. Innovative adjunct techniques, such as focused ultrasound (FUS) and hyperosmotic disruption, may facilitate BBB disruption and enhance drug penetration. However, hemodynamic factors that limit drug residence time remain a limitation. Expanding therapeutic options beyond chemotherapy, including radiotherapy and immunobiologics, may motivate future investigations. While preclinical and clinical studies demonstrate moderate efficacy, larger randomized trials are needed to validate the clinical benefits. Additionally, future directions may involve endovascular sampling for peri-tumoral surveillance; changes in drug formulations to prolong residence time; and the exploration of non-pharmaceutical therapies, like radioembolization and photodynamic therapy. Endovascular strategies hold immense potential in reshaping HGG treatment paradigms, offering targeted and minimally invasive approaches. However, overcoming technical challenges and validating clinical efficacy remain paramount for translating these advancements into clinical care.


  • Top Cited Papers
    Open Access

    Global, Regional, and National Economic Consequences of Stroke

    by Jakob V.E. Gerstl, Sarah E. Blitz, Qing Rui Qu, Alexander G. Yearley, Philipp Lassarén, Rebecca Lindberg, Saksham Gupta, Ari D. Kappel, Juan C. Vicenty-Padilla, Edoardo Gaude, et al.

    BACKGROUND: An understanding of global, regional, and national macroeconomic losses caused by stroke is important for allocation of clinical and research resources. The authors investigated the macroeconomic consequences of stroke disease burden in the year 2019 in 173 countries. METHODS: Disability-adjusted life year data for overall stroke and its subtypes (ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage) were collected from the GBD study (Global Burden of Disease) 2019 database. Gross domestic product (GDP, adjusted for purchasing power parity [PPP]) data were collected from the World Bank; GDP and disability-adjusted life year data were combined to estimate macroeconomic losses using a value of lost welfare (VLW) approach. All results are presented in 2017 international US dollars adjusted for PPP. RESULTS: Globally, in 2019, VLW due to stroke was $2059.67 billion or 1.66% of the global GDP. Global VLW/GDP for stroke subtypes was 0.78% (VLW=$964.51 billion) for ischemic stroke, 0.71% (VLW=$882.81 billion) for intracerebral hemorrhage, and 0.17% (VLW=$212.36 billion) for subarachnoid hemorrhage. The Central European, Eastern European, and Central Asian GBD super-region reported the highest VLW/GDP for stroke overall (3.01%), ischemic stroke (1.86%), and for subarachnoid hemorrhage (0.26%). The Southeast Asian, East Asian, and Oceanian GBD super-region reported the highest VLW/GDP for intracerebral hemorrhage (1.48%). CONCLUSIONS: The global macroeconomic consequences related to stroke are vast even when considering stroke subtypes. The present quantification may be leveraged to help justify increased spending of finite resources on stroke in an effort to improve outcomes for patients with stroke globally.


  • Open Access

    Pseudoaneurysm Formation in a Pediatric Patient After Non-Traumatic Middle Cerebral Artery Dissection With a Rapid Spontaneous Complete Thrombosis

    by Orlando De Jesus, Fausto Lugo Morales, Juan C. Vicenty

    Spontaneous cerebral dissections in children are rare and can be associated with the formation of pseudoaneurysms. The management of these pseudoaneurysms is controversial as they can be treated either by surgery or endovascular techniques. On rare occasions, they may spontaneously thrombose. We present a 12-year-old male without a history of trauma who developed an intracerebral hematoma secondary to a ruptured pseudoaneurysm of the middle cerebral artery that showed a rapid spontaneous complete thrombosis. Five days after his initial diagnostic cerebral digital subtraction angiogram, a follow-up study showed no evidence of the previously observed pseudoaneurysm. Two months later, a computed tomographic angiography of the brain showed no evidence of the pseudoaneurysm. Thrombosed pseudoaneurysms should be closely followed by neuroimaging studies as they may subsequently recanalize.


  • Open Access

    Potential Association Between Acute Colonic Pseudo-Obstruction (Ogilvie Syndrome) and Oral Nimodipine: Report of Two Cases

    by Orlando De Jesus, Jose Sánchez Jiménez, Juan C. Vicenty

    Nimodipine is a calcium channel blocker used for the management of patients with aneurysmal subarachnoid hemorrhage. Oral nimodipine has been rarely implicated in the development of acute colonic pseudo-obstruction (Ogilvie syndrome) in patients treated for aneurysmal subarachnoid hemorrhage. Nimodipine inhibits the transmembrane influx of calcium ions which are essential for the excitation-contraction coupling process of smooth muscle cells. We thought this mechanism of action could predispose patients to develop Ogilvie syndrome. This report aimed to examine the existing literature concerning the potential association between Ogilvie syndrome and nimodipine in patients with aneurysmal subarachnoid hemorrhage. All published cases of aneurysmal subarachnoid hemorrhage associated with Ogilvie syndrome were reviewed. We presented two female patients with aneurysmal subarachnoid hemorrhage produced after a ruptured anterior communicating artery aneurysm who received oral nimodipine and developed Ogilvie syndrome. The patients developed Ogilvie syndrome four to six days after receiving oral nimodipine. These two cases may further support the potential association of Ogilvie syndrome with the use of oral nimodipine during the treatment of patients with aneurysmal subarachnoid hemorrhage.


  • Posterior Cerebral Artery Aneurysm Re-Rupture Following Revascularization for Moyamoya Disease

    by Saksham Gupta, Juan Vicenty-Padilla, Pui Man Rosalind Lai, Xin Zhou, Joshua D. Bernstock, Melissa Chua, Saef Izzy, Mohammad Ali Aziz-Sultan, Rose Du, Nirav J. Patel